Contract facts
NONEEO14042 - TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PH… is a federal NONE award for National Institutes Of Health Niaid held by Revagenix, Inc. Estimated value $26.9M ($21.2M obligated). Current period of performance ends Aug 31, 2026 (potential Oct 31, 2026). Last award drew 12 bidders. Place of performance: SAN DIEGO, CA. Related solicitation HHS-NIH-NIAID-BAA2019-1.
EO14042 - TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES.
Recompete timing
PublicCurrent PoP ended Aug 31, 2026 (7 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRevagenix, Inc — $32.8M obligated across 2 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93020C00018?
75N93020C00018 (Eo14042 - to SELECT a NOVEL) is a National Institutes Of Health Niaid award with an estimated value of $26.9M, currently held by Revagenix, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93020C00018?
National Institutes Of Health Niaid awarded 75N93020C00018 to Revagenix, Inc.
Who is the incumbent on 75N93020C00018?
Revagenix, Inc is the incumbent with $32.8M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.
When does Revagenix, Inc’s 75N93020C00018 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75N93020C00018 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.